CRIS Current Research Information System

TONETTI, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.716
NA - Nord America 4.256
EU - Europa 3.114
SA - Sud America 394
AF - Africa 199
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.165
SG - Singapore 1.609
VN - Vietnam 1.370
CN - Cina 1.366
IT - Italia 1.083
HK - Hong Kong 414
DE - Germania 406
SE - Svezia 354
GB - Regno Unito 314
BR - Brasile 275
IN - India 258
FR - Francia 213
KR - Corea 203
RU - Federazione Russa 137
NL - Olanda 134
JP - Giappone 121
IE - Irlanda 116
FI - Finlandia 106
AT - Austria 64
CI - Costa d'Avorio 64
AR - Argentina 49
ID - Indonesia 47
CA - Canada 42
IQ - Iraq 37
TH - Thailandia 35
ZA - Sudafrica 34
BD - Bangladesh 33
PH - Filippine 33
SC - Seychelles 33
MX - Messico 31
BG - Bulgaria 30
TR - Turchia 28
JO - Giordania 27
CH - Svizzera 26
TW - Taiwan 26
SA - Arabia Saudita 25
TG - Togo 23
PK - Pakistan 19
PL - Polonia 18
AU - Australia 17
ES - Italia 17
RO - Romania 17
UA - Ucraina 16
EC - Ecuador 15
CO - Colombia 14
CL - Cile 12
BE - Belgio 11
PY - Paraguay 11
UZ - Uzbekistan 10
MA - Marocco 9
EG - Egitto 8
LT - Lituania 8
AZ - Azerbaigian 7
HR - Croazia 6
MY - Malesia 6
NG - Nigeria 6
TN - Tunisia 6
KG - Kirghizistan 5
NP - Nepal 5
PE - Perù 5
VE - Venezuela 5
AL - Albania 4
BH - Bahrain 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
PT - Portogallo 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
MD - Moldavia 3
ME - Montenegro 3
BB - Barbados 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BT - Bhutan 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
Totale 13.679
Salva come PNG Salva come JPEG
Città #
Singapore 1.113
Ashburn 539
Hefei 438
Hong Kong 388
Ho Chi Minh City 360
Hanoi 296
Chandler 285
Fairfield 264
Santa Clara 246
Southend 226
Bologna 214
San Jose 212
Seoul 187
Dallas 166
Princeton 142
Boardman 115
Cambridge 114
Woodbridge 114
Dublin 112
New York 112
Seattle 110
Lauterbourg 108
Milan 105
Beijing 100
Wilmington 100
Houston 93
Tokyo 93
Council Bluffs 89
Dong Ket 83
Los Angeles 82
Abidjan 64
Helsinki 60
Da Nang 59
Rome 56
Des Moines 55
Berlin 50
Redondo Beach 48
Ann Arbor 47
Haiphong 43
Shanghai 42
Bengaluru 41
Frankfurt am Main 40
Nuremberg 40
Lappeenranta 38
Westminster 38
Buffalo 35
Jakarta 31
Sofia 30
Turin 29
Vienna 29
Modena 27
Redmond 27
Amman 26
Chicago 26
San Diego 25
São Paulo 24
Lomé 23
Florence 22
Verona 22
Guangzhou 21
Falkenstein 20
Hải Dương 19
Johannesburg 19
London 19
Munich 19
Redwood City 19
Jinan 18
Denver 17
Medford 17
Can Tho 16
Rio de Janeiro 16
Baghdad 15
Nanjing 15
Thái Nguyên 14
Bremen 13
Mumbai 13
Boston 12
Bắc Ninh 12
Miami 12
Tongling 12
Warsaw 12
Xi'an 12
Chennai 11
Falls Church 11
Phoenix 11
Phủ Lý 11
Tappahannock 11
Toronto 11
Amsterdam 10
Bangkok 10
Bern 10
Chiang Mai 10
Haikou 10
Montreal 10
Rimini 10
Riyadh 10
Tân Tiến 10
Yubileyny 10
Atlanta 9
Fuzhou 9
Totale 8.249
Salva come PNG Salva come JPEG
Nome #
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 314
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 310
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 251
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 244
Lung Protective Mechanical Ventilation in Severe Acute Brain Injured Patients: A Multicenter, Randomized Clinical Trial (PROLABI) 243
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia 230
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study 228
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 217
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 198
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 193
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 190
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study 187
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 184
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 177
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 176
Dynamic Arterial Elastance to Predict Mean Arterial Pressure Decrease after Reduction of Vasopressor in Septic Shock Patients 176
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP 175
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 172
Erector spinae plane block: A systematic qualitative review 170
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study 169
Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysis 166
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales 166
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 165
High-Flow Nasal Oxygen for Severe Hypoxemia Oxygenation Response and Outcome in Patients with COVID-19 160
Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs 158
The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series 149
Acute ischemia of the thumb caused by radial artery cannulation 144
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration 143
High Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in COVID-19 Patients 140
Respiratory consequences of intra-abdominal hypertension 139
Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy 138
Mechanical power and VILI: modeling limits and unknowns 137
Complications of Mechanical Ventilation 137
Synergistic effect of static compliance and d-dimers to predict outcome of patients with covid-19-ards: A prospective multicenter study 137
Protective ventilation in patients with acute respiratory distress syndrome related to COVID-19: always, sometimes or never? 134
Individualized positive end-expiratory pressure guided by end-expiratory lung volume in early acute respiratory distress syndrome: study protocol for the multicenter, randomized IPERPEEP trial 133
Effects of mechanical ventilation on the lungs 132
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 131
Alveolar recruitment in acute respiratory distress syndrome: should we open the lung (no matter what) or may accept (part of) the lung closed? 129
Extracorporeal CO2removal (ECCO2R) in patients with stable COPD with chronic hypercapnia: A proof-of-concept study 129
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 127
Extracorporeal CO 2 Removal During Renal Replacement Therapy to Allow Lung-Protective Ventilation in Patients With COVID-19-Associated Acute Respiratory Distress Syndrome 125
Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial 125
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization 125
Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilation 125
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 124
Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up 124
Changes in upper airways microbiota in ventilator-associated pneumonia 123
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study 123
Assignment of ASA-physical status relates to anesthesiologists’ experience: A survey-based national-study 123
Collapse and decollapse in acute respiratory distress syndrome 123
Current knowledge gaps in extracorporeal respiratory support 120
Extracorporeal carbon dioxide removal for treatment of exacerbated chronic obstructive pulmonary disease (ORION): study protocol for a randomised controlled trial 120
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar? 119
Environmental Contamination by SARS-CoV-2 During Noninvasive Ventilation in COVID-19 119
One ventilator for two patients: Feasibility and considerations of a last resort solution in case of equipment shortage 119
Central venous line placement and ultrasound probe damage: A word of caution 118
WSES consensus conference guidelines: Monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours 112
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients 112
Ventilator-related causes of lung injury: the mechanical power 111
Efficacy and safety of lower versus higher CO 2 extraction devices to allow ultraprotective ventilation: Secondary analysis of the SUPERNOVA study 106
The future of mechanical ventilation: Lessons from the present and the past 105
Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs 105
Successful Versus Failed Transition From Controlled Ventilation to Pressure Support Ventilation in COVID-19 Patients: A Retrospective Cohort Study 104
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia? 104
Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set 104
Sustained oxygenation improvement after first prone positioning is associated with liberation from mechanical ventilation and mortality in critically ill COVID-19 patients: a cohort study 104
Driving pressure and mechanical power: New targets for VILI prevention 101
Determinants of energy load in acute respiratory distress syndrome patients 101
Cognitive and affective disorders in critical SARS-CoV-2 patients and caregivers 101
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 100
Will all ARDS patients be receiving mechanical ventilation in 2035? We are not sure 100
Effects of regional perfusion block in healthy and injured lungs 98
Targeting Pseudomonas aeruginosa resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion 97
Erector spinae plane block as a multiple catheter technique for open esophagectomy: a case report 97
Intensive care medicine in 2050: ventilator-induced lung injury 95
Volutrauma, Atelectrauma, and Mechanical Power 94
Opening pressures and atelectrauma in acute respiratory distress syndrome 94
Positive end-expiratory pressure: How to set it at the individual level 93
Reclassifying acute respiratory distress syndrome 91
Positive end-expiratory pressure and mechanical power 90
How best to set the ventilator on extracorporeal membrane lung oxygenation 89
Rescue therapies for acute respiratory distress syndrome: What to try first? 89
The perils of dental vacation: Possible anaesthetic and medicolegal consequences 89
Regional physiology of ARDS 88
Monitoring lung impedance changes during long-term ventilator-induced lung injury ventilation using electrical impedance tomography 88
Platelet drop and fibrinolytic shutdown in patients with sepsis 87
Extracorporeal CO2 Removal: The Minimally Invasive Approach, Theory, and Practice 86
Increased duration and similar outcomes of V-V ECLS in patients with Covid-19 Ards compared to non-Covid ards: single center experience 86
Quadratus Lumborum Block for Incarcerated Hernia Repair in a Multi-Morbid Elderly Patient: A Letter to Editor 85
Local anesthetic spread during erector spinae plane block 84
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review 84
The lower respiratory tract microbiome of critically ill patients with COVID-19 82
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus 81
Safety of Early Tracheostomy Performed by Intensivists in Acute Brain-injured Patients: A 1-Year Observational Study 81
Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? We are not sure 81
Inspiratory recruitment in acute respiratory distress syndrome 80
Pathophysiology of COVID-19-associated acute respiratory distress syndrome - Authors' reply 78
Correction to: Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs (Journal of Intensive Care, (2020), 8, 1, (80), 10.1186/s40560-020-00499-4) 77
TDM-Based Approach for Properly Managing Intravenous Isavuconazole Treatment in a Complex Case Mix of Critically Ill Patients 71
Totale 13.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021334 0 0 0 0 0 0 0 0 0 73 49 212
2021/20221.278 47 32 66 57 128 130 31 71 88 166 257 205
2022/20231.365 127 167 71 175 110 83 60 99 248 43 86 96
2023/2024860 36 98 85 59 107 145 72 53 35 62 62 46
2024/20252.751 94 327 250 216 395 175 248 141 90 173 187 455
2025/20266.498 598 809 714 588 579 354 807 242 1.300 507 0 0
Totale 14.111